Leading MTP organisations sign MoU to benefit sector through collaboration


Wednesday, 26 October 2016, Melbourne, Australia - MTPConnect and AusBiotech have signed a memorandum of understanding (MoU) to work together in undertaking activities to accelerate the growth of the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.

The agreement between AusBiotech, Australia's biotechnology industry organisation advocating for over 3,000 members, and MTPConnect, an independent, not-for-profit organisation working to boost the MTP sector in Australia, will foster greater collaboration between the two organisations to deliver their missions of engaging with, strengthening and establishing the sector nationally and as an Asia-Pacific hub.

The MoU was announced today at the AusBiotech 2016 national conference in Melbourne as part of International BioFest 2016, bringing together national and international organisations for the largest-ever gathering of the biotech ecosystem in Australia.

Sue MacLeman, CEO of MTPConnect, said that the agreement will be an important milestone for the sector.

"AusBiotech do incredible work for the biotech and medtech sector in Australia, with over 30 years of experience and a loyal membership base, and we are delighted to have signed an MoU to ensure that our two organisations will work closely for the benefit of the sector.

"Together, MTPConnect and AusBiotech will be able to have significant impact on boosting innovation, sustainability and growth of medtech and biotech in Australia, achieving greater commercialisation and competitiveness in the global market through joint advocacy, training, and fostering international connections."

Glenn Cross, CEO of AusBiotech, said:

"AusBiotech have supported MTPConnect since its formation in 2015, and we look forward to working in partnership with the industry growth centre in the future. This MoU will drive our already aligned goals to devise tactics that will deliver real-world, positive outcomes to the Australian medical technology and pharmaceutical sector."